|
⚲
|
| Keyboard |
| Czuczman Myron
✚
|
|
|---|---|
| CIK # | 0001817716 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001817716] | |
| 4 | [0001817716] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Citius Oncology Inc | |
| Czuczman Myron | |
| Citius Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
|
2024-12-12 | Grant | 400,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Stock Option (Right to Purchase Common Stock) · derivative
|
2024-11-07 | Grant | 300,000 | $0.00 | |
|
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
|
2024-08-12 | Grant | 466,667 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Stock Option (Right to Purchase Common Stock) · derivative
|
2023-10-10 | Grant | 300,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Stock Option (Right to Purchase Common Stock) · derivative
|
2022-10-04 | Grant | 300,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Stock Option (Right to Purchase Common Stock) · derivative
|
2021-10-11 | Grant | 300,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Stock Option (Right to Purchase Common Stock) ) · derivative
|
2020-07-14 | Grant | 500,000 | $0.00 |